Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 12;40(2):115-128.
doi: 10.5937/jomb0-29341.

Role of biochemical markers in the monitoring of COVID-19 patients

Pablo Letelier  1 , Nicole Encina  1 , Pablo Morales  1 , Alejandra Riffo  1 , Halett Silva  1 , Ismael Riquelme  2 , Neftalí Guzmán  1
Affiliations

Role of biochemical markers in the monitoring of COVID-19 patients

Pablo Letelier et al. J Med Biochem. .

Abstract
in English, Serbian

COVID-19 is an infectious disease caused by the SARSCoV-2 virus, which has given rise to a global sanitary emergency. The clinical characteristics of COVID-19 are varied and can range from an asymptomatic infection to a mild to severe pneumonia. Recent studies have shown that different laboratory parameters become altered in these patients, and as such are useful as biomarkers to assess the progression of the disease and categorize patients that may present a severe and/or fatal clinical condition. This review analyzes biochemical and immunological markers that become altered in COVID-19 patients and their impact on different organs at a hepatic, cardiac, renal and pancreatic level, as well as markers of inflammation, analyzing their implications in the evolution of the disease.

COVID-19 je infektivno oboljenje izazvano SARS CoV-2 virusom, koje je dovelo do globalne pandemije. Kliničke karakteristike COVID-19 su različite i kreću se od asimptotske infekcije do srednje ili teške pneumonije. Nedavne studije ukazuju da se različiti laboratorijski parametri menjanju kod ovih pacijenata, i kao takvi su korisni kao bio-markeri za praćenje napredovanja oboljenja i kategorizaciju pacijenata koji mogu imati teška i/ili fatalna klinička stanja. U ovom radu su analizirani biohemijski i imunološki markeri koji se menjaju kod COVID-19 pacijenata i pokazatelj su stanja različitih organa kao što su jetra, srce, bubrezi, pankreas, i koriste se kao markeri inflamacije, a za potrebe procene napredovanja i toka oboljenja.

Keywords: COVID-19; SARS-CoV2; biomarkers; coronavirus disease; laboratory diagnosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors stated that they have no conflicts of interest regarding the publication of this article.

References

    1. Abuelgasim E, Saw L J, Shirke M, Zeinah M, Harky A. COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities. Mosby Inc; 2020. - PMC - PubMed
    1. Gorbalenya A E, Baker S C, Baric R S, de Groot R J, Drosten C, Gulyaeva A A, et al. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. 2020;5(4):536. doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
    1. Lai C C, Shih T P, Ko W C, Tang H J, Hsueh P R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3) doi: 10.1016/j.ijantimicag.2020.105924. - DOI - PMC - PubMed
    1. Estevão A. Artículo de opinión: COVID-19 Acta Radiológica Portuguesa. 2020;32(1):1.
    1. Hamming I, Timens W, Bulthuis M, Lely A T, Navis G J, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631. doi: 10.1002/path.1570. - DOI - PMC - PubMed

LinkOut - more resources